Market Newsdesk

LISLE, Ill., April 14, 2026 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) will release its earnings for the first quarter 2026 at approximately 8:00 a.m. (ET) on Wednesday, April 29, 2026.

A conference call to discuss first quarter 2026 results with management is scheduled for Wednesday, April 29, 2026 at 10:00 a.m. (ET). The conference call can be accessed by registering online at CTS Corporation Q1 2026 Earnings Call, at which time registrants will receive dial-in information as well as a conference ID.

A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://investors.ctscorp.com/news-events/events-and-presentations/ where it will be archived for one year.

About CTS

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides highly engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets.

For more information, visit www.ctscorp.com.

Contact

Ashish Agrawal
Vice President and Chief Financial Officer

CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA

Telephone: +1 (630) 577-8800
E-mail: [email protected]

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a top complex litigation law firm, is investigating Hub Group Inc. (NASDAQ: HUBG) (“Hub Group” or the “Company”) for potential violations of the federal securities laws.

On February 5, 2026, Hub Group announced that it would restate its financial statements for the first, second, and third quarters of 2025 due to an error that resulted in the understatement of purchased transportation costs and accounts payable. The Company disclosed that the total reduction to accounts payable and purchased transportation costs related to the identified error was $77 million for the nine months ended September 30, 2025. The Company delayed its full earnings release and stated that it is continuing to assess the potential impact on its financial statements for 2023 and 2024, indicating the scope of the accounting errors may extend beyond 2025.

“Our investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,” said attorney Andrea Farah, Lowey Dannenberg, P.C. partner and head of the firm’s securities practice.

If you suffered a loss of more than $50,000 in Hub Group securities, and wish to participate, or learn more about your eligibility, click here, or contact our attorneys Andrea Farah ([email protected]) at (914)733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914)733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:  [email protected] 

SOURCE: Lowey Dannenberg

SANTA MONICA, Calif., April 14, 2026 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and influence people who play video games across the digital landscape, announced today that it has been nominated for Best Brand or Commerce Integration for the Company’s ‘HI-CHEW x Fortnite: Immerse Yourself in Flavor’ campaign, created in partnership with Carmichael Lynch, in the 30th Annual Webby Awards. Hailed as the “Internet’s highest honor” by The New York Times, The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS), comprised of Internet industry experts.

The ‘HI-CHEW Immerse Yourself in Flavor’ campaign, created in partnership with Carmichael Lynch, successfully transformed the candy brand into a playable universe within Fortnite Creative. The fully-realized HI-CHEW gaming universe included five custom minigames and three permanent creator-built worlds, driving significant player engagement with an average session length of 28.32 minutes. The campaign delivered exceptional performance metrics, including over 3.87 million total plays and an 8,196 peak concurrent user count, ultimately demonstrating a performance increase of over 1,000% versus non-branded alternatives.

“Nominees like Super League are raising the bar for creativity and innovation on the Internet,” said Nick Borenstein, General Manager of The Webby Awards. “At the 30th Annual Webby Awards, this recognition feels especially meaningful. It’s no small feat to stand out among nearly 13,000 entries, and this year’s work reflects the energy, originality, and ambition shaping the Internet right now”.

”The Webby nomination is a huge validation of our strategy to create lasting, engaging brand experiences,” said Rhiannon Apple, EVP, Client Strategy at Super League. “The ‘HI-CHEW x Fortnite: Immerse Yourself in Flavor’ campaign, our third together, garnered over 3.87 million plays and pioneered a creator incubator for permanent gaming content, setting new benchmarks for immersive brand integration and performance”.

As a nominee, Super League is also eligible to win a Webby People’s Voice Award, which is voted online by fans across the globe. From now until April 16th, HI-CHEW fans can cast their votes at https://vote.webbyawards.com/PublicVoting#/2026/apps-software-immersive/immersive-content/best-brand-or-commerce-integration.

Winners will be announced on Tuesday, April 21, 2026, and honored in a star-studded show at Cipriani Wall Street. Winners will have an opportunity to deliver one of The Webby Awards’ famous 5-Word Speeches. Past 5-Word Speeches include: Kim Kardashian’s “Nude Selfies Till I Die”; Prince’s “Everything You Think is True”; Steve Wilhite’s “It’s Pronounced “Jif” not ‘Gif’; NASA’s “Houston We Have A Webby”; and SZA’s “The Internet Scares Me. Thanks”.

About Super League Enterprise:

Super League (Nasdaq: SLE) connects brands with the 3.5 billion-person global gaming population through advertising and branded content programs across gaming and digital media platforms. The Company generates revenue by delivering these programs through proprietary interactive formats, creator content, immersive experiences, data-driven insights, and strategic campaign services designed to improve marketing performance. By translating player behavior into actionable intelligence, Super League serves as a trusted partner helping brands reach and influence consumers who play video games. With a deep understanding of this highly engaged yet under-monetized audience, Super League is positioned to capture an increasing share of brand advertising spend as the market evolves.

About Morinaga America, Inc.:

Established in 2008, Morinaga America, Inc. is the official distributor of HI-CHEW®, HI-SOFT™, and Chargel™ in the United States. Morinaga America, Inc. (marketing and sales) and Morinaga America Foods, Inc. (manufacturing) are wholly-owned subsidiaries of Morinaga & Co., Ltd., which began in 1899 as the first, modern candy maker and producer of chocolates in Japan. In 2015, Morinaga America, Inc. opened its first United States manufacturing facility in North Carolina. With over 200 flavors of HI-CHEW® having debuted in Japan, Morinaga America, Inc. has introduced the United States market to the best of Japanese confectionery.

About The Webby Awards

Hailed as the “Internet’s highest honor” by The New York Times, The Webby Awards is the leading international awards organization honoring excellence on the Internet, including Websites and Mobile Sites; Video; Advertising, Media & PR; Apps & Software; Social; Games; Podcasts; Creators and AI. Established in 1996, The Webby Awards received over 13,000 entries from all 50 states and over 70 countries worldwide this year. The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS).

Find The Webby Awards Online

Website: webbyawards.com
Instagram: @thewebbyawards
Linkedin: The Webby Awards
TikTok: @thewebbyawards
X: @TheWebbyAwards
YouTube: youtube.com/thewebbyawards
Facebook: Facebook.com/TheWebbyAwards

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.

Forward Looking Statements can be identified by words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements include all statements other than statements of historical fact, including, without limitation, all statements regarding the private placement, including expected proceeds, Super League’s ability to maintain compliance with the Listing Rules of the Nasdaq Capital Market, statements regarding expected operating results and financial performance (including the Company’s commitment to and ability to achieve Adjusted EBITDA-positive results in Q4), strategic transactions and partnerships, and capital structure, liquidity, and financing activities. These statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which the Company operates, management’s current beliefs, and certain assumptions made by the Company, all of which are subject to change.

Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that are difficult to predict, and that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Important factors include, but are not limited to: the Company’s ability to adequately utilize the funds received recent financings; the Company’s ability to execute on cost reduction initiatives and strategic transactions; customer demand and adoption trends; the timing, outcome, and enforceability of any patent applications; the ability to successfully integrate new technologies and partnerships; platform, regulatory, macroeconomic and market conditions; the Company’s ability to maintain compliance with Nasdaq Capital Market continued listing standards; access to, and the cost of, capital; and the other risks and uncertainties described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal years ended December 31, 2024 and December 31, 2025, and other filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date of this release or to
reflect the occurrence of unanticipated events

Investor Relations Contact:

Kirsten Beduya
Quantum Media Group
[email protected]

Media Contact:

I’m Sunshine Sachs Morgan & Lylis
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fd4b8d10-439c-4d10-997d-fd026f0f26bc

ATHENS, Greece, April 14, 2026 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today announced that, through a separate wholly-owned subsidiary, it has signed a Memorandum of Agreement to sell its oldest vessel, the 2010-built, 105,304 dwt Aframax tanker vessel, M/T P. Aliki, to Trafigura Maritime Logistics Pte. Ltd. for a gross sale price of US$42.65 million. The vessel is expected to be delivered to the new owners in or around the end of the third quarter 2026, subject to customary closing conditions and upon expiration of her current US$30,000 per day time charter with Pakistan National Shipping Corporation.

The M/T P. Aliki currently serves as part of the collateral for the Company’s outstanding credit facility with Alpha Bank S.A. Part of the net proceeds from the sale will be applied to repay approximately US$12.8 million in accordance with the terms of the loan agreement.

The Company acquired the M/T P. Aliki in the fourth quarter of 2022 for a gross purchase price of US$36.5 million.

Commenting on this sale, Andreas Michalopoulos, the Company’s Chief Executive Officer, stated:

“The sale of the M/T P. Aliki is an integral part of our fleet renewal strategy, which combines opportunistic acquisitions of modern vessels and newbuilding orders with the divestitures of our older vessels. Over the past twelve months, the average age of our fleet has declined from 14 years to 8 years on a pro forma basis, following the pre-announced sale of the M/T P. Sophia and the sale of the M/T P. Aliki, and will decrease further upon delivery of our newbuilding vessels. Age is not the only factor, as we now boast a highly specified and energy efficient fleet.

“Our cash reserves are expected to increase from approximately US$50 million as of the end of 2025, to approximately US$175 million, taking into account our materialized bond tap issue and delivery of our third newbuilding M/T P. Marseille in January 2026, and pro forma the expected proceeds from the sale of the M/T P. Sophia and the net proceeds from the sale, following debt repayment, of the M/T P. Aliki . This significant cash increase will, among other initiatives, further support the funding for the construction of our two Suezmax tanker vessels scheduled for delivery in October 2028 and May 2029 at China Shipbuilding Trading Co. Ltd. (“CSTC”) and Shanghai Waigaoqiao Shipbuilding Co. Ltd. (“SWS”).”

About the Company

Performance Shipping Inc. is a global provider of shipping transportation services through its ownership of tanker vessels. The Company employs its fleet on spot voyages, through pool arrangements, and on time charters.

Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include, but are not limited to, statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts including with respect to employment of our fleet and vessel deliveries. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “will,” “may,” “should,” “expect,” “targets,” “likely,” “would,” “could,” “seeks,” “continue,” “possible,” “might,” “pending” and similar expressions, terms or phrases may identify forward-looking statements.

The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including, without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs, or projections.

In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to: the strength of world economies, fluctuations in currencies and interest rates, general market conditions, including fluctuations in charter rates and vessel values, changes in demand in the tanker shipping industry, changes in the supply of vessels, changes in worldwide oil production and consumption and storage, changes in our operating expenses, including bunker prices, crew costs, drydocking and insurance costs, our future operating or financial results, availability of financing and refinancing including with respect to vessels we agree to acquire, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, the length and severity of epidemics and pandemics, including COVID-19, and their impact on the demand for seaborne transportation of petroleum and other types of products, general domestic and international political conditions or events, including “trade wars”, armed conflicts including the war in Ukraine and the war in the Middle East, the imposition of new international sanctions, acts by terrorists or acts of piracy on ocean-going vessels, potential disruption of shipping routes due to accidents, labor disputes or political events, vessel breakdowns and instances of off-hires and other important factors. Please see our filings with the US Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties.

Corporate Contact:
Andreas Michalopoulos
Chief Executive Officer, Director and Secretary
Telephone: +30-216-600-2400
Email:[email protected]
Website: www.pshipping.com

Investor and Media Relations:
Edward Nebb
Comm-Counsellors, LLC
Telephone: + 1-203-972-8350
Email:[email protected]

PHILADELPHIA, April 14, 2026 (GLOBE NEWSWIRE) — National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) on behalf of investors who purchased or acquired Eos shares during the period from November 5, 2025 through February 26, 2026 (the “Class Period”).

Investor Deadline:

Investors who purchased or acquired

Eos

securities during the Class Period may, no later than

May 5, 2026

, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,


CLICK HERE

.

Eos, headquartered in Edison, NJ, manufactures energy storage solutions for utility-scale, microgrid-based, and industrial applications.

According to the lawsuit, Eos and its senior executives failed to disclose to investors that: (1) the Company was unable to achieve the production and capacity utilization necessary to reach previous guidance; (2) the Company’s battery line downtime was significantly in excess of industry norms; (3) it took significantly longer for Eos’s automated bipolar production to hit quality targets; and (4) the Company’s inadequate systems and processes prevented it from ensuring reasonably accurate guidance.

When investors learned the true state of Eos’ operations and finances, shares fell $4.39 per share, more than 39%, to close at $6.74 per share on February 26, 2026.

If you are an Eos investor and would like to learn more about this action,




CLICK HERE




or please contact Berger Montague: Andrew Abramowitz at




[email protected]




or (215) 875-3015, or Caitlin Adorni at




[email protected]




or (267)764-4865.

About Berger Montague

Berger Montague is one of the nation’s preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.

For more information or to discuss your rights, please contact:

Andrew Abramowitz
Berger Montague
(215) 875-3015
[email protected] 

Caitlin Adorni
Berger Montague
(267) 764-4865
[email protected] 

DENVER, April 14, 2026 (GLOBE NEWSWIRE) — Recombinant spider silk produced by living organisms, ultra-light carbon fiber composites, and next-generation aerogels are no longer lab curiosities, they are already in hospitals, on battlefields, in performance apparel, and on spacecraft. These breakthroughs are delivering measurable gains in strength, sustainability, weight reduction, and functionality across medicine, military applications, high-performance textiles, and aerospace. This is materials science building the technologies of tomorrow, right now.

The Science Behind Tomorrow’s Materials

Advanced materials science sits at the intersection of biology, chemistry, and engineering. Recombinant spider silk is spun by genetically engineered silkworms that produce proteins with crystalline β-sheets for strength and amorphous regions for elasticity, creating a fiber stronger than steel, tougher than Kevlar, yet fully biodegradable. Carbon fiber composites offer 5× the strength of aluminum at 30-50% less weight, while aerogels (often called “frozen smoke”) deliver extreme thermal insulation with 99% air by volume.

These technologies are scaling commercially and being adopted by public companies turning lab discoveries into real-world products.

Medicine: Precision Healing and Regenerative Solutions

In healthcare, biomaterials enable targeted therapies and faster recovery. Nanoparticles deliver chemotherapy directly to tumors, hydrogels regenerate cartilage and stimulate electrical signals for wound healing, and 3D-printed scaffolds support tissue engineering. Self-healing polymers and biocompatible implants reduce rejection rates. The foundational polymers and composites driving these advances come from the same supply chains powering defense and aerospace.

Military & Defense: Lighter, Smarter, Lower-Collateral Solutions

Defense applications demand materials that reduce weight, enhance stealth, and minimize collateral damage. L3Harris Technologies (NYSE: LHX) leads in carbon-fiber bomb casings for the BLU-129/B and Focused Lethality Munition. These proprietary carbon-fiber-wound bodies vaporize on impact, delivering full explosive effect while eliminating dangerous shrapnel, ideal for urban operations. L3Harris has delivered over 1,000 units in partnership with Boeing and the U.S. Air Force.

Avient Corporation (NYSE: AVNT) brings Dyneema, the world’s strongest ultra-high-molecular-weight polyethylene fiber, to ballistic vests, helmets, and vehicle armor. In early 2026 Avient ramped production to meet surging global defense demand, delivering hundreds of thousands of protective products to allied forces. Lighter than water yet able to stop bullets cold, Dyneema complements emerging biological fibers in next-gen soldier systems.

High-Performance Textiles: Sustainable Super-Fibers Meet Smart Wearables

High-performance textiles have evolved into intelligent systems that monitor health, regulate temperature, and harvest energy. Conductive fibers, phase-change materials, and nanomaterials create fabrics that adapt in real time, perfect for athletes, first responders, and troops.

The standout biological breakthrough comes from Kraig Biocraft Laboratories (OTCQB: KBLB), which genetically engineers silkworms to produce recombinant spider silk, branded as Dragon Silk, Monster Silk, and SpydaSilk. Because it is created by a living organism, the material is fully biodegradable, unlike petroleum-based synthetics. Pound-for-pound it beats steel in strength and Kevlar in toughness, while remaining ultra-light, elastic, and skin-friendly.

As of April 2026, Kraig Labs has smashed production records, achieving over 1.3 metric tons of spider-silk cocoons in a single month, five times their previous best, and is deploying roughly one million proprietary silkworm eggs across expanded facilities in Vietnam. The company is on track for multi-ton monthly output, with a stated goal of 10 metric tons per month. Current orders focus on luxury and high-performance apparel: elite athletic gear, technical outerwear, and premium fashion collections from brands seeking sustainable premium fabrics.

The next wave is already in motion. Kraig’s Project Atlas program (accelerated in March 2026) is developing advanced spider-silk variants specifically for defense and industrial use, lighter, more flexible body armor, ballistic shoot packs, and protective composites. This biological approach offers a sustainable edge that synthetic fibers like Dyneema cannot yet match, while both technologies point to a future of greener, higher-performing textiles.

Space Tiles, Thermal Protection & Hypersonic Applications

Re-entry heat exceeding 3,000°F once limited spacecraft to single-use designs. The Space Shuttle’s silica tiles (99% air) and reinforced carbon-carbon components proved reusable thermal protection was possible. Today, Aspen Aerogels (NYSE: ASPN) is pushing the envelope with next-generation aerogel insulation. These ultra-light materials, direct descendants of NASA’s “frozen smoke”, provide superior thermal management in far less weight and space than traditional ceramics.

Aspen’s aerogels are already being qualified for hypersonic vehicles, reusable spacecraft like Starship’s evolving heat shield, and high-heat drone/fighter applications. The same technology that protects against re-entry plasma is now enabling longer-endurance drones and more efficient fighter engines, directly linking space tech with the carbon-fiber airframes Hexcel supplies.

Market Outlook & Why 24/7 Market News Is Bullish on Advanced Materials in 2026

The convergence of production scale-ups, defense spending, sustainability mandates, and AI-accelerated discovery is creating a multi-billion-dollar opportunity. Recombinant spider silk, carbon fiber, and aerogels are already reducing weight, increasing performance, and lowering environmental impact across sectors. Challenges remain, cost curves, regulatory timelines, and supply-chain scaling, but the trajectory is clear.

**Sources**

– Kraig Biocraft Laboratories press releases & corporate updates, March–April 2026 (Project Atlas deployment and production records) – https://www.kraiglabs.com   

– L3Harris Technologies product capability statements and contract announcements, 2025–2026 (carbon-fiber munition casings) – https://www.l3harris.com   

– Hexcel Corporation investor presentations and JEC World 2026 exhibits (F-35, CCA drone composites) – https://www.hexcel.com  

– Avient Corporation Q1 2026 earnings and defense order updates (Dyneema ballistic production ramp) – https://www.avient.com   

– Aspen Aerogels technical literature and NASA heritage documentation (aerogel thermal protection systems) – https://www.aerogel.com   

– National Geographic, March 2026 cover feature on recombinant spider silk commercialization , which is available at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026 or https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering.

– Industry reports on synthetic silk and advanced composites markets, March–April 2026

About 24/7 Market News

In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact [email protected] to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

CONTACT:

24/7 Market News
[email protected]

University to Evaluate Omni One Across Rehabilitation and Simulation Settings

Collaboration Highlights Potential Expansion into Healthcare While Virtuix Continues Advancing Consumer and Defense Initiatives

AUSTIN, Texas, April 14, 2026 (GLOBE NEWSWIRE) — Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced the delivery of an Omni One omni-directional treadmill system to Florida Gulf Coast University (“FGCU”), where faculty and students in the Marieb College of Health & Human Services will evaluate the system for use in physical therapy, occupational therapy, neurological rehabilitation, fall prevention, and clinical simulation applications.

“The Virtuix system presents strong potential as both a medical device and a clinical simulation platform. Its immersive 360-degree locomotion technology allows for objective assessment of gait, balance, stride mechanics, postural control, and reaction time. This makes it highly applicable across physical therapy and rehabilitation. The integrated safety harness creates a secure environment for progressive therapeutic interventions while minimizing fall risk,” said Dr. Joseph P. Buhain, Director of Interprofessional Simulation and Emerging Technology, Marieb College of Health & Human Services at Florida Gulf Coast University.

In addition to potential rehabilitation applications, Omni One may also support simulation-based education by enabling learners to navigate realistic virtual environments, including hospital units, home settings, community spaces, and disaster scenarios. Virtuix believes these capabilities can enhance situational awareness through interactive, movement-based experiences that train executive function and memory.

“We are excited to work with FGCU and evaluate the use of Omni One for medical applications,” said Jan Goetgeluk, CEO of Virtuix. “This collaboration potentially opens another large market for Virtuix in addition to our consumer and defense businesses. More importantly, we believe our Omni technology has the power to help patients worldwide by making physical therapy and rehabilitation exercises more engaging and effective.”

Physical therapy and rehabilitation represent a large and rapidly growing market opportunity. The global physical therapy market is valued at approximately $26 billion in 2025 and is projected to nearly double to approximately $50 billion by 2034, driven by an aging population, the rising prevalence of chronic and musculoskeletal conditions, and growing interest in technology-enabled care. Virtuix believes its immersive, full-body movement platform is well positioned to address this growing demand through differentiated rehabilitation and simulation use cases.

Virtuix remains focused on two core markets alongside this emerging medical application opportunity: consumer and defense. On the consumer side, the Company recently joined Meta’s “Made for Meta” program, which is expected to make Omni One compatible with Meta Quest headsets and content, expanding access to the world’s largest XR user base. In the defense segment, Virtuix recently announced an Omni One delivery to the U.S. Marine Corps and a development agreement with the U.S. Navy, building on prior defense traction that includes sales to the U.S. Army at West Point, the U.S. Air Force Academy, and Yokota Air Base.

About Virtuix

Virtuix Inc. (NASDAQ: VTIX) is a leading manufacturer of full-body virtual reality systems for consumer, enterprise, and defense markets. The company’s premier portfolio of “Omni” omni-directional treadmills enables players to walk and run in 360 degrees inside video games and other virtual reality applications. With a commitment to innovation, Virtuix continues to push the boundaries of XR and AI, delivering immersive experiences to users worldwide. For more information, visit virtuix.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Visit Us on Social Media:

LinkedIn





Instagram





Facebook





YouTube





TikTok





X

Company Contact

Lauren Premo
Virtuix Inc.
[email protected]

Investor Relations Contact

Chris Tyson
MZ Group
Direct: 949-491-8235
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2ba7d28b-48bc-45db-b49e-929295456dc1

SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) — Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the use of the MyChoice^® Test for prostate cancer patients as a companion diagnostic for Lynparza^® (olaparib). With this approval, clinicians can now order the MyChoice Test to determine homologous recombination deficiency (HRD) status for patients with ovarian cancer, and BRCA1/2 status for breast and prostate cancers.

“Expanding the MyChoice test into prostate cancer marks an important milestone for Myriad Genetics in Japan,” said Brian Donnelly, Chief Commercial Officer, Myriad Genetics. “Previously, MyChoice testing was only reimbursed under Japan’s National Health Insurance (NHI) for breast and ovarian cancer patients, so this new approval broadens access to critical genomic insights that help clinicians make informed treatment decisions for their patients. This also reflects Myriad’s continued focus on adding high value precision medicine tests to its Cancer Care Continuum portfolio.”

According to the World Cancer Research Fund, more than 100,000 men are newly diagnosed with prostate cancer annually in Japan, and a portion of those patients will be diagnosed with or later progress to metastatic castration-resistant (mCRP).

“The reimbursement approval of MyChoice for prostate cancer provides a new testing option for patients with castration-resistant prostate cancer. In addition to the previously available germline BRCA1/2 testing, the inclusion of tumor-based testing is expected to expand the number of patients who may benefit from treatment with PARP inhibitors,” said Dr. Hiroji Uemura, Project Professor, Department of Urological Oncology, Yokohama City University Graduate School of Medicine.

About the MyChoice Test

The MyChoice Test offers comprehensive homologous recombination deficiency (HRD) testing enabling physicians to identify patients with tumors that have lost the ability to repair double-stranded DNA breaks, resulting in increased susceptibility to DNA-damaging drugs such as platinum drugs or PARP inhibitors. The MyChoice tests comprise tumor sequencing of the BRCA1 and BRCA2 genes and a composite of three proprietary technologies (loss of heterozygosity, telomeric allelic imbalance and large-scale state transitions). The test is offered for breast, ovarian, and prostate cancer indications in Japan. For more information about Myriad Genetics in Japan, visit myriadgenetics.jp.

About Myriad Genetics

Myriad Genetics is a leading molecular diagnostic and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. For more information, visit myriad.com.

Myriad Genetics Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements that the inclusion of tumor-based testing is expected to expand the number of patients who may benefit from treatment with PARP inhibitors. These “forward-looking statements” are management’s expectations of future events as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated. Such factors include those risks described in the company’s filings with the U.S. Securities and Exchange Commission, including the company’s Annual Report on Form 10-K filed on February 24, 2026, as well as any updates to those risk factors filed from time to time in the company’s Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Myriad is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.

Investor Contact 

Matt Scalo 
(801) 584-3532 
[email protected] 

Media Contact 

Kate Schraml
(224) 875-4493
[email protected]